Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP28 inhibits trisulfur. 1 / 1

| 1

➶

reach

"Using an ATP based cell viability assay (Cell Titer-Glo), we screened a small library of 316 FDA approved chemical compounds and identified the PLK1 inhibitor rigosertib as a compound that selectively impairs the viability of USP28 depleted cells (XREF_FIG and Table S3)."

29880484

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...